Apotheca Biosciences (PCFP) Stock Price, News & Analysis

Company Overview

Apotheca Biosciences, Inc. engages in the development of cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industries. Its products include transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids. The company was founded on October 6, 2014 and is headquartered in St. Petersburg, FL.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 264,300 shs
• Average Volume: 45,056 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PCFP Stock Analysis - Frequently Asked Questions

How do I buy shares of Apotheca Biosciences?

Shares of PCFP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Apotheca Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Apotheca Biosciences investors own include Cronos Group (CRON), America First Multifamily Investors (ATAX), Jumia Technologies (JMIA), Kinder Morgan (KMI), Sprott Resource (SCP), SMART Global (SGH) and Tilray Brands (TLRY).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PCFP
• CIK: 1632053
• Web: www.cannabisleafinc.co
• Phone: (727) 228-3994
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A